MONKASTA

This brand name is authorized in Croatia, Estonia, Germany, Italy, Lithuania, Malta, Poland, Romania, Spain.

Active ingredients

The drug MONKASTA contains one active pharmaceutical ingredient (API):

1	Montelukast UNII U1O3J18SFL - MONTELUKAST SODIUM
	Montelukast is an orally active compound which binds with high affinity and selectivity to the CysLT1 receptor. Τhe CysLT type-1 (CysLT1) receptor is found in the human airway (including airway smooth muscle cells and airway macrophages) and on other pro-inflammatory cells (including eosinophils and certain myeloid stem cells). CysLTs have been correlated with the pathophysiology of asthma and allergic rhinitis.
	Read more about Montelukast

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MONKASTA Film-coated tablet	MPI, EU: SmPC	Medicines Authority (MT)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03DC03	Montelukast	R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DC Leukotriene receptor antagonists
Discover more medicines within R03DC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	09765017, 09765023, 09765046
EE	Ravimiamet	1289673, 1289684, 1289695, 1289707, 1289718, 1289729, 1289741, 1289752, 1289763, 1289774, 1289785, 1289796, 1289808, 1289819, 1289820, 1289831, 1289842, 1289864, 1289875, 1289909, 1289910, 1289921, 1289932, 1289943, 1289954, 1289965, 1289976, 1289987, 1289998, 1290002, 1290013, 1290024, 1290035, 1290046, 1290057, 1290068, 1290079, 1290080, 1355532, 1769036, 1769047, 1769058, 1769069, 1769070, 1769081
ES	Centro de información online de medicamentos de la AEMPS	72930, 72931, 72932
HR	Agencija za lijekove i medicinske proizvode	HR-H-054532530, HR-H-715082312, HR-H-823027772
IT	Agenzia del Farmaco	040398051, 040398202, 040398354
LT	Valstybinė vaistų kontrolės tarnyba	1004931, 1004932, 1004954, 1025137, 1025138, 1025139, 1033663, 1033664, 1033665, 1033666, 1033667, 1033670, 1033671, 1033672, 1033673, 1033674, 1033675, 1033676, 1033677, 1033679, 1033680, 1033681, 1033682, 1033683, 1033684, 1033685, 1033686, 1033687, 1033688, 1033689, 1033690, 1033691, 1034544, 1034545, 1034546, 1034547, 1034548, 1034549, 1034550, 1034551, 1034552, 1034553, 1034554, 1034555, 1034556, 1089495
MT	Medicines Authority	MA982/01002, PI1438/05602A, PI908/22601A
PL	Rejestru Produktów Leczniczych	100198921, 100198967, 100201400
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W56684001, W56684002, W56684003, W56684004, W56684005, W56684006, W56684007, W56684008, W56684009, W56684010, W56684011, W56684012, W56684013, W56684014, W56684015, W56685001, W56685002, W56685003, W56685004, W56685005, W56685006, W56685007, W56685008, W56685009, W56685010, W56685011, W56685012, W56685013, W56685014, W56685015, W56686001, W56686002, W56686003, W56686004, W56686005, W56686006, W56686007, W56686008, W56686009, W56686010, W56686011, W56686012, W56686013, W56686014, W56686015